Public Criticism Puts Pressure On Chinese Government To Reduce Drug Prices
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Chinese media recently reported that some drugs in hospitals are sold at 13 times their ex-factory prices, which led the National Development and Reform Commission to release new measures on drug pricing, UBS said June 23
You may also be interested in...
China's New Drug Price Policies Will Favor Big Distributors, Restrict Smaller Ones
SHANGHAI - China is releasing a series of new policies to fight bribery in the pharmaceutical industry and reduce drug prices, which will benefit large distributors such as SinoPharm, Shanghai Pharmaceutical Group and Jointown, said an expert in a Citi research conference call July 19
China's New Drug Price Policies Will Favor Big Distributors, Restrict Smaller Ones
SHANGHAI - China is releasing a series of new policies to fight bribery in the pharmaceutical industry and reduce drug prices, which will benefit large distributors such as SinoPharm, Shanghai Pharmaceutical Group and Jointown, said an expert in a Citi research conference call July 19
China's New Drug Price Policies Will Favor Big Distributors, Restrict Smaller Ones
New guidelines that tighten rules on profit-margin ceilings and lock in distributor mark-ups will have no negative impact on large distributors while forcing small companies to change their business model, industry organization exec says.